Scientific Respiratory Symposium, Paris June 2010

References

• MauadTSilvaLFFSantosMAAbnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthmaAJRCCM2004170857862
   Google Scholar
• KimVRogersTJCrinerGJNew concepts in the pathobiology of chronic obstructive pulmonary diseaseProc Am Thorac Soc2008547848518453359
   PubMedGoogle Scholar
• YanaiMSekizawaKOhruiTSite of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressureJ Appl Physiol1992723101610231568955
   PubMed Web of Science ®Google Scholar
• BorgstromLBengtssonTDeromEPauwelsRVariability in lung deposition of inhaled drug, within and between asthmatic patientsInt J Pharm200019322723010606786
   PubMed Web of Science ®Google Scholar
• HamidQAPeripheral inflammation is more important than central inflammationRespir Med199791Suppl A11129474360
   PubMed Web of Science ®Google Scholar
• LeachCLDavidsonPJHasselquistBEBoudreauRJLung deposition of hydrofluoroalkane-134a beclom-ethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasoneChest200212251051612171824
   PubMed Web of Science ®Google Scholar
• LipworthBJJacksonCMPharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionateBr J Clin Pharmacol19994886686810594492
   PubMed Web of Science ®Google Scholar
• Usmani BiddiscombeMFBarnesPJRegional Lung Deposition and Bronchodilator Response as a Function of beta2-Agonist Particle SizeAJRCCM2005172656657
   Google Scholar
• NewmanSPA comparison of lung deposition patterns between different asthma inhalersJ Aerosol Med19958Suppl 3S2126 discussion S2710157895
   PubMedGoogle Scholar
• LeachCLImproved delivery of inhaled steroids to the large and small airwaysRespir Med199892Suppl A389850357
   PubMed Web of Science ®Google Scholar
• LeachCLImproved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasoneEur Respir J199812134613539877489
   PubMed Web of Science ®Google Scholar
• LeachCLTargeting inhaled steroidsInt J Clin Pract Suppl199896232710344030
   PubMedGoogle Scholar
• UsmaniOSBiddiscombeMFBarnesPJRegional lung deposition and bronchodilator response as a function of beta2-agonist particle sizeAJRCCM2005172656657
   Google Scholar
• VeenJCBeekmanAJBelEHSterkPJRecurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodeAm J Respir Crit Care Med20001611902190610852764
   PubMed Web of Science ®Google Scholar
• BerryMHargadonBMorganAAlveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthmaEur Respir J20052598699115929952
   PubMed Web of Science ®Google Scholar
• Van Essen-ZandvlietEEHughesMDWaalkensHJEffects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthmaAm Rev Respir Dis19921465475541355640
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis and Management of Asthma in Children 5 years and Younger, Global Initiative for Asthma (GINA)2006 http://www.ginasthma.orgAccessed April 14, 2011
   Google Scholar
• BrandPLBaraldiEBisgaardHDefinition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approachEur Respir J2008321096110018827155
   PubMed Web of Science ®Google Scholar
• JanssensHMDe JongsteJCHopWCExtra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway modelChest20031232083208812796192
   PubMed Web of Science ®Google Scholar
• JanssensHMDe JongsteJCFokkensWJThe Sophia Anatomical Infant Nose-Throat (Saint) modelJ Aerosol Med2001443344111791684
   PubMedGoogle Scholar
• SchüeppKGJauernigJJanssensHMIn vitro determination of the optimal particle size for nebulized aerosol delivery to infantsJ Aerosol Med20051822523515966777
   PubMedGoogle Scholar
• MallolJRattraySWalkerGCookDRobertsonCFAerosol deposition in infants with cystic fibrosisPediatr Pulmonol1996212762818726152
   PubMed Web of Science ®Google Scholar
• SchüeppKGStraubDMöllerAWildhaberJHDeposition of aerosols in infants and childrenJ Aerosol Med20041715315615294065
   PubMedGoogle Scholar
• KöhlerEJilgGAvenariusSJorchGLung deposition after inhalation with various nebulizers in preterm infantsArch Dis Child Fetal Neonatal Ed200893F275F27918192330
   PubMed Web of Science ®Google Scholar
• SchüeppKGDevadasonSGRollerCAerosol delivery of nebulizer budesonide in young children with asthmaRespir Med20091031738174519540100
   PubMed Web of Science ®Google Scholar
• AgertoftLLaulundLWHarrisonLIPedersonSInfluence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in childrenPediatr Pulmonol20033519219912567387
   PubMed Web of Science ®Google Scholar
• NayakALanierRWeinsteinSStamponePWelchMEfficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthmaChest20021221956196512475833
   PubMed Web of Science ®Google Scholar
• Van AalderenWMPriceDDe BaetsFMPriceJBeclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthmaRespir Med20071011585159317254760
   PubMed Web of Science ®Google Scholar
• SzeflerSJWarnerJStaabDSwitching from conventional to extrafine aerosol beclomethasone dipropionate therapy in childrenJ Allergy Clin Immunol2002110455012110818
   PubMed Web of Science ®Google Scholar
• Inhaled Particles VII, International Symposium on Inhaled Particles16–22 September 1991Edinburgh, ScotlandPergamon Press1992 0080408419
   Google Scholar
• SkonerDPMasperoJBanerjiAssessment of the long-term safety of inhaled ciclesonide on growth in children with asthmaPediatrics200812111418166550
   PubMed Web of Science ®Google Scholar
• PedersenSWarnerJWahnUGrowth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulationsPediatrics2002109e9212042586
   PubMed Web of Science ®Google Scholar
• CarrollNElliotJMortonAJamesAThe structure of large and small airways in nonfatal and fatal asthmaAm Rev Respir Dis19931474054108430966
   PubMed Web of Science ®Google Scholar
• WagnerEMLiuMCWeinmannGGPermuttSBleeckerERPeripheral lung resistance in normal and asthmatic subjectsAm Rev Respir Dis199014135845882178524
   PubMed Web of Science ®Google Scholar
• IrvinCGPakJMartinRJAirway-parenchyma uncoupling in nocturnal asthmaAm J Respir Crit Care Med2000161505610619797
   PubMed Web of Science ®Google Scholar
• KraftMDjukanovicRWilsonSHolgateSTMartinRJAlveolar tissue inflammation in asthmaAm J Respir Crit Care Med1996154150515108912772
   PubMed Web of Science ®Google Scholar
• GoldinJGTashkinDPKleerupECComparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airwaysJ Allergy Clin Immunol1999104258267
   PubMed Web of Science ®Google Scholar
• FordPARussellREKBarnesPJICS and COPD: Time to clear the airInt J Chron Obstruct Pulmon Dis2009428929019684862
   PubMedGoogle Scholar
• WeatherallMShirtcliffePTraversJBeasleyRUse of cluster analysis to define COPD phenotypesEur Respir J20103647247420930198
   PubMed Web of Science ®Google Scholar
• DrummondMBDasenbrookECPitzMWInhaled corticosteroids in patients with stable chronic obstructive pulmonary diseaseJAMA200826:3002407241619033591
   PubMed Web of Science ®Google Scholar
• StarkieHJBriggsAHChambersMGPharmacoeconomics in COPD: Lessons for the futureInt J Chron Obstruct Pulmon Dis20083718818488430
   PubMedGoogle Scholar
• BrittonMThe burden of COPD in the UK.: results from the Confronting COPD surveyRespir Med200397Suppl CS71S7912647945
   PubMed Web of Science ®Google Scholar
• HoleDJWattGCDavey-SmithGHartCLGillisCRHawthorneVMImpaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ19963137117158819439
   PubMed Web of Science ®Google Scholar
• BatemanEBousheyHABousquetCan guideline-defined asthma control be achieved?Am J Respir Crit Care Med200417083684415256389
   PubMed Web of Science ®Google Scholar
• BriggsAHBousquetJWallaceMVCost-effectiveness of asthma control: an economic appraisal of the GOAL studyAllergy20066153153616629780
   PubMed Web of Science ®Google Scholar
• CalverleyPMAAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
   PubMed Web of Science ®Google Scholar
• BriggsAGlickHALozano-OrtegaGIs treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH studyEur Respir J20103553253919717476
   PubMed Web of Science ®Google Scholar
• JonassonGCarlsenKHMowinckelPAsthma drug adherence in a long term clinical trialArch Dis Child20008333033310999870
   PubMed Web of Science ®Google Scholar
• SmithGCPellJPParachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trialsBMJ20033271459146114684649
   PubMed Web of Science ®Google Scholar
• VestboJThe TORCH study GroupThe TORCH (TOwards a Revolution in COPD Health) survival study protocolEur Respir J20042420621015332386
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• HerlandKAkselsenJPSkjønsbergOHBjermerLHow representative are clinical study patients with asthma or COPD for a larger and “real life” population of patients with obstructive lung diseaseRespir Med200599111915672843
   PubMed Web of Science ®Google Scholar
• GiraudVRocheNMisuse of corticosteroid metered-dose inhaler is associated with decreased asthma stabilityEur Respir J20021924625111866004
   PubMed Web of Science ®Google Scholar
• ClatworthyJPriceDRyanDHaughneyJHorneRThe value of self-report assessment of adherence, rhinitis and smoking in relation to asthma controlPrim Care Respir J20091830033019562233
   PubMedGoogle Scholar
• ChaudhuriRLivingstonEMcMahonADEffects of smoking cessation on lung function and airway inflammation in smokers with asthmaAm J Respir Crit Care Med200617412713316645173
   PubMed Web of Science ®Google Scholar
• BarnesPJItoKAdcockIMCorticosteroid resistance in chronic obstructive pulmonary diseaseLancet200436373173315001333
   PubMed Web of Science ®Google Scholar
• FaulerJFrölichJCCigarette smoking stimulates cysteinyl leukotriene production in manEur J Clin Invest19972743479041376
   PubMed Web of Science ®Google Scholar
• GreenRHBrightlingCEMcKennaSAsthma exacerbations and sputum eosinophil counts: a randomised controlled trialLancet20023601715172112480423
   PubMed Web of Science ®Google Scholar
• ThomasMvon ZiegenweidtJLeeAJPriceDHigh-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational studyJ Allergy Clin Immunol200912311612118986690
   PubMed Web of Science ®Google Scholar
• ZeigerRSSzeflerSJPhillipsBRResponse profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthmaJ Allergy Clin Immunol2006117455216387583
   PubMed Web of Science ®Google Scholar
• GreeningAPIndPWNorthfieldMShawGAdded salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidLancet19943442192247913155
   PubMed Web of Science ®Google Scholar
• A pragmatic single-blind RCT and health economic evaluation of leukotriene receptor antagonists in primary care at steps two and three of the national asthma guidelines (ELEVATE) http://www.hta.ac.uk/project/1204.aspAccessed April 14, 2011
   Google Scholar
• BjermerLBisgaardHBousquetJMontelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: a one year, double blind, randomized controlled trialBMJ200332789114563743
   PubMed Web of Science ®Google Scholar
• PriceDHaughneyJSimsEEffectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRDJournal of Asthma and Allergy20114374721698214
   PubMedGoogle Scholar
• FiremanPPrennerBMVinckenWDemedtsMMolSJCohenRMLong-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosolAnn Allergy Asthma Immunol20018655756511379808
   PubMed Web of Science ®Google Scholar
• PriceDMartinRJBarnesNPrescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational studyJ Allergy Clin Immunol201012651151820692026
   PubMed Web of Science ®Google Scholar
• RabeKFVermeirePASorianoJBMaierWCClinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) studyEur Respir J20001680280711153575
   PubMed Web of Science ®Google Scholar
• GodardPHuasDSohierBPribilCBoucotIAsthma control in general practice: a cross-sectional survey of 16,580 patientsPresse Med20055:3419 Pt 11351135716292185
   PubMed Web of Science ®Google Scholar
• MegasFThe “Compli’Asthme” therapeutic observation survey on good use of inhaled drugs for asthma: perception by general practitionersRev Pneumol Clin20046015816515292825
   PubMedGoogle Scholar
• MolimardMRaherisonCLignotSAssessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary careJ Aerosol Med20031624925414572322
   PubMedGoogle Scholar
• NewmanSPWeiszAWTalaeeNClarkeSWImprovement of drug delivery with a breath actuated pressurized aerosol for patients with poor inhaler techniqueThorax1991467127161750017
   PubMed Web of Science ®Google Scholar
• GiraudVRocheNMisuse of corticosteroid metered-dose inhaler is associated with decreased asthma stabilityEur Respir J20021924625111866004
   PubMed Web of Science ®Google Scholar
• Al-ShowairRAMPearsonSBChrystynHThe potential of a 2Tone Trainer to help patients use their metered-dose inhalersChest2007131177617400675
   PubMed Web of Science ®Google Scholar
• PriceDThomasMMitchellGNiziolCFeatherstoneRImprovement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI)Respir Med12003971121912556005
   PubMed Web of Science ®Google Scholar